Relmada Therapeutics, Inc. (RLMD)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

5

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Sep-24 5:47 PM View:	09-Sep-24 Private Purchase $33.28K	Casamento Charles J Director		Relmada Therapeutics, Inc. - RLMD	100% 0 to 13.0K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 5:46 PM View:	09-Sep-24 Private Purchase $64.75K	Kelly Paul Edward Director		Relmada Therapeutics, Inc. - RLMD	13% 187.29K to 212.29K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 5:47 PM View:	11-Sep-24 Purchase $153.71K	Traversa Sergio Chief Executive Officer Director		Relmada Therapeutics, Inc. - RLMD	57% 244.02K to 384.02K	0	0	--	--	Show Txns Hide Txns

11-Sep-24 5:46 PM View:	11-Sep-24 Purchase $71.15K	Shenouda Maged Chief Financial Officer		Relmada Therapeutics, Inc. - RLMD	153% 34.9K to 88.33K	0	0	--	--	Show Txns Hide Txns